Encouraging Early Outcomes of Treatment With Arsenic Trioxide Combined With Chemotherapy for Alveolar Rhabdomyosarcoma in Children: 4 Case Reports

BACKGROUND: Alveolar rhabdomyosarcoma (ARMS) is a subtype of rhabdomyosarcoma characterized by its aggressive behavior and poor prognosis, highlighting the need for novel treatment options. Arsenic trioxide (ATO) has been shown to specifically inhibit tumor growth and the metastasis of ARMS in vitro...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Xiaomin, Xiong, Xilin, Li, Yang, Feng, Chuchu, Liu, Hongyan, Wu, Pingping, Li, Chunmou, Weng, Wenjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586416/
https://www.ncbi.nlm.nih.gov/pubmed/34778066
http://dx.doi.org/10.3389/fonc.2021.751623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586416/
https://www.ncbi.nlm.nih.gov/pubmed/34778066
http://dx.doi.org/10.3389/fonc.2021.751623

Ejemplares similares